Natalie Maimon
Dr. Natalie Maimon is the head of the lung tumor service at Meir Hospital, where she has been instrumental in advancing targeted therapies for lung cancer patients, particularly those with ALK mutations. Her work has contributed to significant improvements in the prognosis and quality of life for patients, as evidenced by recent studies showing remarkable results in controlling the disease.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Israel | 1 | 9.00 | 0.08% | +0% | 9,216,900 | 7,706 | $400,000 | 334$ |
| Totals | 1 | 9,216,900 | 7,706 | $400,000 | 334$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Israel:
Dr. Natalie Maimon explains the significance of targeted treatments for lung cancer patients with ALK mutations.
9